In 1560, a French diplomat brought a strange plant’s seeds from Lisbon to the French court. He presented them to Queen Catherine de Medici as a remedy…

In 1560, a French diplomat brought a strange plant's seeds from Lisbon to the French court. He presented them to Queen Catherine de Medici as a remedy...

Tobacco kills more than eight million people every year. Over the past century, smoking has claimed around one hundred million lives, more than both World Wars combined. Yet billions of people still buy it every day, with the risks printed directly on the package. The journey from sacred smoke to global industry took roughly five hundred years, and at every step, the plant was reinvented: medicine, sin, symbol of freedom, subject of legal disputes.

Thumbnail

Behind each transformation stood real people, priests and kings, inventors and entrepreneurs, scientists and lawyers, whose decisions shaped what tobacco would become. Around five thousand years before Christ, Maya tribes in the highlands of what is now Mexico discovered a plant with broad green leaves. When dried and burned, inhaling its smoke produced a mild dizziness and a feeling believed to connect the user with the supernatural. It became known as tobacco, and it quickly moved far beyond the status of a wild plant.

Maya priests inhaled its smoke, believing it carried their prayers to the spirits. For a long time, smoking was reserved for priests and rulers, while ordinary people were forbidden from taking part. The plant was also used as medicine, to treat insect bites, cleanse wounds, and relieve pain. Over time, it spread across Mesoamerica and North America, and among some tribes the pipe became part of political life as well, used during negotiations, the signing of agreements, and the welcoming of guests.

Tobacco became a tool for sealing trust between peoples. By 1492, when Christopher Columbus’s ships reached the Caribbean, tobacco was already widespread. Columbus’s sailors described the locals as “those who drank smoke. ” One of them, Rodrigo de Jerez, tried smoking during the expedition.

When he returned to Spain and lit one in public, his neighbors believed the smoke was a sign of demonic possession and reported him to the Inquisition. He was sentenced to seven years in prison, the first documented criminal punishment for smoking in European history. It was far from the last. Similar punishments would be repeated across continents for the next two centuries.

But by the time de Jerez was released, tobacco was already regular cargo aboard Spanish ships, not as a curiosity but as a commodity with known demand. By the middle of the sixteenth century, tobacco had reached the royal courts of Europe. In 1560, the French diplomat Jean Nicot brought its seeds to France and presented them to Queen Catherine de Medici as a remedy for her migraines. The plant was later named Nicotiana in his honor, giving us the word nicotine.

Tobacco quickly gained a reputation as a universal medicine, prescribed for toothaches, asthma, rheumatism, and even protection against the plague. Not every ruler welcomed it. King James I of England published A Counterblast to Tobacco in 1604, calling smoking harmful to the brain and dangerous to the lungs, and raised the import duty by four thousand percent. It did nothing to reduce demand.

Elsewhere, the reaction was far harsher. Ottoman Sultan Murad IV imposed the death penalty for smoking and reportedly roamed Istanbul in disguise to catch offenders. In Persia, smokers were punished by having molten lead poured down their throats. In Russia, Tsar Michael I ordered flogging for a first offense and execution for a second.

The authorities were less concerned about health than about money flowing abroad and a difficult-to-control habit spreading rapidly. In almost no country did these bans survive more than a generation or two. Rulers changed, decrees were repealed or ignored, but once the habit had taken root in everyday life, it outlived every individual king and sultan. By the end of the seventeenth century, tobacco was so deeply woven into the global economy that the question was no longer whether it could be stopped, but who would profit from it most.

The modern cigarette first appeared, according to one account, in early nineteenth-century Seville, where poor residents wrapped leftover tobacco from discarded cigar butts in thin paper as a cheaper alternative. The practice spread to France, and during the Crimean War of the 1850s, British and French soldiers adopted it from their Ottoman allies. Until the 1880s, cigarettes were rolled entirely by hand, and even an experienced worker could produce no more than four a minute. That severely limited production, prompting the tobacco company Allen and Ginter to offer a reward of seventy-five thousand dollars to anyone who could build a machine capable of rolling cigarettes mechanically.

The solution came from an eighteen-year-old Virginian with no formal engineering education, James Bonsack. In 1880, he built and patented a machine capable of rolling more than two hundred cigarettes per minute, fifty times faster than manual labor. He brought it to Allen and Ginter for testing, expecting the prize. He never got the money.

The company rejected the invention on quality grounds, claiming machine-rolled cigarettes were drier than hand-rolled ones, though historical accounts still include claims that the demonstration was deliberately sabotaged, since hand-rollers saw the machine as a threat to their livelihoods. Allen and Ginter never paid the reward. Bonsack then offered his invention to others. One man accepted: James Buchanan Duke.

Duke was an ambitious outsider, the son of a North Carolina tobacco farmer, searching for a way to outmaneuver stronger competitors. He did more than simply adopt the machine. Working with Bonsack, he invested in refining the technology and solving the quality problems that had led to its rejection. By the early 1880s, his factory was the only one in the United States producing cigarettes by machine on an industrial scale, giving him a decisive advantage for years.

Duke devoted an unusually high share of revenue to advertising, gave away free cigarettes to create demand, and steadily bought out smaller competitors. He placed collectible cards featuring celebrities and athletes inside cigarette packs, knowing children and teenagers would buy more cigarettes to complete the sets. By 1890, his American Tobacco Company controlled about ninety percent of the US tobacco market, creating what was effectively a monopoly. In 1911, the US Supreme Court ruled it illegal and ordered the company broken into several smaller firms.

But the model of mass production had already become the foundation of the industry, and dismantling a single corporation did nothing to change the market’s direction. Mechanization made cigarettes so cheap they became affordable to almost everyone. During the First World War, cigarettes were officially included in military rations for soldiers on both sides. General John Pershing declared that supplying troops with tobacco was as important as supplying ammunition, while President Woodrow Wilson ordered cigarettes classified as an essential military supply.

Tobacco companies shipped millions of packs to the front free of charge, a long-term investment in the habits of an entire generation of young men, many of whom had never smoked before but now received cigarettes alongside their daily rations for months or years. Soldiers returned home carrying not only the experience of war but a deeply ingrained habit of smoking. Smoking rates among men rose sharply. Women, however, rarely smoked, since a woman smoking in public was considered improper.

By the late 1920s, tobacco companies had built production capacity that exceeded actual demand among male smokers, making expansion to women a strategic necessity. That expansion was handled not through direct brand advertising but by changing society’s attitude toward smoking itself. In 1929, Lucky Strike hired Edward Bernays, the nephew of Sigmund Freud and one of the founders of modern public relations. During New York City’s Easter parade, he arranged for a carefully selected group of young women to light cigarettes in front of reporters he had personally invited.

He called the cigarettes “torches of freedom” and presented the event to the press not as a tobacco advertisement but as a symbolic act in the fight for women’s equality. The photographs appeared in newspapers across the country the next day, with most articles framing the event as a milestone in women’s emancipation, with little mention of its commercial purpose. Over the following years, smoking among American women increased significantly. Bernays later organized other campaigns in the same spirit, persuading restaurant owners to list cigarettes on their menus as a kind of dessert and encouraging fashion designers to market ashtrays and cigarette cases as stylish accessories.

He described his work as the engineering of consent, believing mass society could be guided through symbols and images rather than direct persuasion. Marketing historians would later look back on the 1929 campaign as the moment advertising ceased to be merely a way of informing people about a product and became a tool for reshaping social norms. During the 1940s and 1950s, tobacco advertisements routinely featured doctors claiming certain brands were gentler on the throat. One of Camel’s most famous campaigns declared that more doctors smoked Camel than any other brand, a slogan many consumers interpreted as a medical endorsement.

At the same time, a very different picture was emerging behind the scenes. In 1950, independent research groups in the United States and the United Kingdom published the first statistical studies linking smoking to lung cancer. In 1953, scientists at the Sloan Kettering Institute experimentally demonstrated that tobacco tar applied to the skin of laboratory mice caused malignant tumors. Tobacco executives were well aware of these findings.

In December 1953, industry representatives met at the Plaza Hotel in New York to develop a unified strategy of denial. The following month, they published a document titled A Frank Statement to Cigarette Smokers, claiming the link between smoking and cancer had not been proven and promising to fund their own research. The statement appeared as full-page advertisements in hundreds of newspapers, an unprecedented public relations campaign designed to reassure the public before scientific evidence could take hold. The companies did establish a research committee, but internal documents made public decades later during court proceedings revealed its true purpose was not to investigate the issue but to create doubt.

One internal memo stated the strategy bluntly: “Doubt is our product. ” The strategy succeeded not because its arguments were scientifically convincing but because it told people what they already wanted to hear. For a smoker accustomed to a morning cigarette, it was far easier to believe the evidence was inconclusive than to abandon a long-established habit overnight. Tobacco companies built decades of delay on that psychological inertia.

In 1964, the US Surgeon General released a landmark report officially recognizing smoking as a proven cause of lung cancer and other serious diseases. Warning labels followed, along with a ban on television advertising for cigarettes and the first major lawsuits against tobacco companies. In the 1990s, the industry’s position became even more difficult as former executives and employees began testifying in court. Jeffrey Wigand, who had served as vice president of research and development at Brown and Williamson, testified under oath that the company had deliberately manipulated nicotine levels to make cigarettes more addictive while publicly denying that nicotine caused addiction.

After agreeing to give an interview to CBS, he was sued by the company for violating his non-disclosure agreement, and according to Wigand, his family began receiving anonymous threats. His story later became the basis for the film The Insider. The turning point came with the 1998 Master Settlement Agreement, under which forty-six US states and the nation’s largest tobacco companies agreed that the companies would pay more than two hundred six billion dollars over twenty-five years to reimburse states for the public cost of treating smoking-related diseases. The agreement also imposed major restrictions on tobacco advertising, including bans on certain advertising characters and the direct sponsorship of youth-oriented events.

Testimony from Wigand and other former insiders proved decisive, because for the first time the courts were presented not only with statistical evidence but with internal company documents and first-hand accounts from people who had worked inside the industry. The argument that the evidence was inconclusive became impossible to sustain once it emerged that the companies had known the truth internally for years. After sales declined and regulations tightened in the United States and Western Europe, tobacco companies redirected their marketing budgets to regions with weaker regulations and younger, faster-growing populations: Asia, Africa, and Latin America. More than eighty percent of the world’s smokers now live in low- and middle-income countries, where companies use promotional tactics closely resembling those employed in the United States decades earlier, sponsoring local sporting and music events, distributing free samples near schools and universities, and placing billboards where advertising restrictions are weak or non-existent.

At the same time, a new category of products entered the market: electronic cigarettes. Manufacturers initially promoted them as a safer alternative for adult smokers who wanted to quit. But devices featuring fruit and dessert flavors, along with brightly colored designs, attracted large numbers of teenagers who had never smoked before. One of the world’s largest e-cigarette manufacturers was ultimately fined hundreds of millions of dollars for marketing practices that targeted minors.

Regulators responded in different ways, some restricting flavored vaping products, others introducing age limits. Yet the overall pattern remained strikingly familiar: a new product entered the market claiming greater safety, gained popularity among an audience the previous product had failed to reach, and only afterward came under intense regulatory scrutiny. The tobacco industry has changed remarkably little over the past century and a half. Packaging, flavors, and methods of distribution have evolved, but the underlying strategy has remained the same.

Find an audience the previous product did not reach, and offer it a new form of the same substance. The history of tobacco is a repeating cycle. A plant used in sacred religious rituals became a commodity sold as medicine, then a product of mass industrial manufacturing, then a cultural symbol of freedom in advertising, then the subject of systematic scientific deception in the pursuit of profit, and finally a global industry that, when confronted with regulation in one market, shifts its well-tested methods to another with fewer protections. Behind the thin paper cylinder on a store shelf lies five hundred years of religious ceremonies, royal bans, industrial innovation, advertising manipulation, scientific deception, and courtroom battles.

At every stage, decisions were made by people who possessed information unavailable to the ordinary consumer, and that gap between what the industry knew and what the public knew shaped the course of events throughout this entire history. From the priest inhaling sacred smoke atop a pyramid temple to the courtroom where lawyers read aloud a corporation’s internal correspondence, the journey of a single plant has stretched across five centuries, and it is still not over. Countries change, products evolve, and even the substance inside the package changes, but the principle by which the industry continues to sell what it has long understood to be dangerous remains recognizable in every new era.